Bulletin
Investor Alert

Adamis Pharmaceuticals Corp.

NAS: ADMP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 16, 2022, 7:43 p.m.

/zigman2/quotes/205166351/composite

$

0.42

Change

-0.04 -9.60%

Volume

Volume 65,072

Quotes are delayed by 20 min

/zigman2/quotes/205166351/composite

Today's close

$ 0.38

$ 0.46

Change

+0.08 +20.71%

Day low

Day high

$0.39

$0.50

Open

52 week low

52 week high

$0.31

$1.48

Open

Insider Actions for Adamis Pharmaceuticals Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/18/2022 Dennis J. Carlo
President & CEO; Director
10,490   Disposition at $0.6 per share. 6,294
03/18/2022 David J. Marguglio
SVP and Chief Business Officer; Director
11,859   Disposition at $0.6 per share. 7,115
03/18/2022 Ronald B. Moss
Chief Medical Officer
8,199   Disposition at $0.6 per share. 4,919
03/18/2022 David C. Benedicto
Chief Financial Officer
3,603   Disposition at $0.61 per share. 2,197
12/09/2021 David J. Marguglio
SVP and Chief Business Officer; Director
13,000   Gift at $0 per share. 0
12/01/2021 Dennis J. Carlo
President & CEO; Director
47,870   Disposition at $0.78 per share. 37,338
12/01/2021 David J. Marguglio
SVP and Chief Business Officer; Director
50,757   Disposition at $0.78 per share. 39,590
12/01/2021 Ronald B. Moss
Chief Medical Officer
35,553   Disposition at $0.78 per share. 27,731
12/01/2021 David C. Benedicto
Chief Financial Officer
13,554   Disposition at $0.78 per share. 10,572
02/21/2021 Dennis J. Carlo
President & CEO; Director
27,822   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2021 Robert O. Hopkins
Chief Financial Officer
22,258   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2021 David J. Marguglio
SVP and Chief Business Officer; Director
22,258   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2021 Ronald B. Moss
Chief Medical Officer
13,911   Derivative/Non-derivative trans. at $0 per share. 0
11/20/2020 Robert O. Hopkins
Chief Financial Officer
35,000   Disposition at $0.41 per share. 14,350
11/20/2020 David J. Marguglio
SVP and Chief Business Officer; Director
35,000   Disposition at $0.4 per share. 14,000
11/18/2020 Dennis J. Carlo
President & CEO; Director
10,665   Disposition at $0.41 per share. 4,372
11/18/2020 Robert O. Hopkins
Chief Financial Officer
7,229   Disposition at $0.41 per share. 2,963
11/18/2020 David J. Marguglio
SVP and Chief Business Officer; Director
8,532   Disposition at $0.41 per share. 3,498
11/18/2020 Ronald B. Moss
Chief Medical Officer
8,532   Disposition at $0.41 per share. 3,498
11/18/2020 Karen K. Daniels
VP of Operations
5,333   Disposition at $0.41 per share. 2,186
09/29/2020 Robert O. Hopkins
Chief Financial Officer
20,000   Disposition at $0.8 per share. 16,000
09/29/2020 David J. Marguglio
SVP and Chief Business Officer; Director
20,000   Disposition at $0.8 per share. 16,000
08/18/2020 Dennis J. Carlo
President & CEO; Director
10,929   Disposition at $0.87 per share. 9,508
08/18/2020 Robert O. Hopkins
Chief Financial Officer
7,418   Disposition at $0.87 per share. 6,453
08/18/2020 David J. Marguglio
SVP and Chief Business Officer; Director
8,749   Disposition at $0.87 per share. 7,611
08/18/2020 Ronald B. Moss
Chief Medical Officer
8,749   Disposition at $0.87 per share. 7,611
08/18/2020 Karen K. Daniels
VP of Operations
5,480   Disposition at $0.87 per share. 4,767
05/19/2020 Karen K. Daniels
VP of Operations
4,855   Disposition at $0.56 per share. 2,718
05/18/2020 Dennis J. Carlo
President & CEO; Director
9,913   Disposition at $0.56 per share. 5,551
05/18/2020 Robert O. Hopkins
Chief Financial Officer
6,532   Disposition at $0.56 per share. 3,657
05/18/2020 David J. Marguglio
SVP and Chief Business Officer; Director
7,734   Disposition at $0.56 per share. 4,331
05/18/2020 Ronald B. Moss
Chief Medical Officer
7,736   Disposition at $0.56 per share. 4,332

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
4 Sales
0
34,151
Last 6 months
0 Purchases
9 Sales
0
194,885
Last 12 months
0 Purchases
9 Sales
0
194,885

Officers and Executives

Dr. Dennis J. Carlo
President, Chief Executive Officer & Director
Mr. David C. Benedicto
Chief Financial & Accounting Officer
Dr. Ronald B. Moss
Chief Medical Officer
Dr. Thomas H. Moll
Vice President-Research
Mr. David J. Marguglio
Director, Chief Business Officer & Senior VP
Dr. Meera J. Desai
Independent Director
Link to MarketWatch's Slice.